r hwiR De'riGri
694-9755
118 Walton
Hair Design
694-9755
April Graham
Specializing in
CORPS CUTS
WEEKLY SPECIALS
Monday, March 18, 2002
INTERNaJ
the BAlJ
Grenade attack in Pakista
Protestant church kills fl\
ISLAMABAD, Pakistan
(AP) — A grenade attack on a
Protestant church packed with
Sunday worshippers killed five
people — including an American
woman and her daughter — in an
assault clearly aimed at
Pakistan’s foreign community.
No group claimed responsi
bility for the attack, in which at
least one young man in black —
some witnesses said two — ran
through the center of the church
hurling grenades. But suspicion
fell on Islamic extremists.
Ten Americans were among
the 45 people injured, most of
whom were foreigners, police
and hospitals said. One body
remained unidentified late
Sunday, and officials said it
may be the assailant.
President Bush condemned
the attack on the Protestant
International Church and called
it an act of terrorism. He
pledged to find those responsi
ble and bring them to justice.
Britain’s Foreign Secretary
Jack Straw said the assault was
aimed at undermining
Pakistan’s pro-U.S. president at
a time when he is trying to quell
Islamic fundamentalism fol
lowing the Taliban’s fall in
neighboring Afghanistan.
The attack occurred at 10:50
a.m. during a sermon before 60 to
70 worshippers. Dozens of police
and soldiers rushed to the scene.
The church, about 400 yards
from the U.S. Embassy, is locat
ed in the guarded diplomatic
quarter in the heart of Pakistan’s
capital and primarily serves the
foreign community. The over
whelming majority of Pakistanis
are Muslim and few Pakistani
Christians live in Islamabad.
Survivors spoke of deafening
blasts, choking smoke and pan
demonium. They said terrified
parents screamed for their chil
dren and stunned worshippers
dived beneath chairs and behind
cement pillars as bits of flesh
were hurled through the air.
Parishioners sobbed and
called out “Brother! Brother!”
as they tried to find friends and
family amid the chaos.
u
It was horrific.
There was a horri
ble smell and we
could barely
breathe
Elisabeth Mundhenk
victim
Parents groped to find their
way downstairs, where their
children were attending Sunday
School. Other parishioners
feared touching the wounded,
because unexploded grenades
lay near their bodies.
Witnesses gave conflicting
reports on the number of attack
ers. Late Sunday, senior police
superintendent Nasir Khan
Durrani said authorities believed
only one attacker was involved.
Durrani said the assailant
may have died in the attack.
"There was blood, blood,
blood, intestines lying on the
floor.” said Elisabeth Mundhenk,
54, of Hamburg. Germany as she
awaited treatment for shrapnel
wounds at a hospital. “It was hor
rific. There was a horrible smell
and we could barely breathe.”
Mark Robinson of San
Clemente, Calif., who was
being treated at a clinic for a
minor leg injury, described
“total pandemonium.”
“Everyone panicked,”
Robinson said. “I saw one
woman on the steps with a piece
of shrapnel in her carotid artery.
She bled to death right there.”
The U.S. Embassy identified
the dead Americans as Barbara
Green and her daughter Kristen
Wormsley, a senior at the
American School in Islamabad.
Green and her husband.
Milton Green, worked at the
U.S. Embassy — she in admin
istration and he in the computer
division. Milton Green and the
couple’s young son were also
injured but not seriously,
according to police.
The other dead included one
Church atta
Grenades were .
Proteaent church inti
Pakistan on Sunday^;
people and injuriig^
^77
jf ArGHAHtSTAN
PAKISTri
Footb «
spring
-4»>c»ViVY ^
Afghan, one Pakisur
one unidentified,
officials said.
In addition
Americans, 12 PaL:
Iranians, one la
Ethiopian and oik
were injured, police
government said tae
also included Sn
Afghans, Swiss.
Australians andCani
Six or seven wen:
condition. District L
Mehmood Khan Nani
British aid won
Parham, 36. told Bra
Association news asr j
attacker ran through th:
the church, hurling ep
| Four q
for NC
ksTBkM ty'hn 1 Religious police allegedly block resc
London $294
Paris $335
Amsterdam $488
Madrid... $477
Rio de Janeiro...$772
San Jose C.R. ...$461
BUDGET HOTELS
for as little as
A NIGHT!!!
fai Fares are round-trip.
rf<| Restrictions may ^P^Y-
Tax not includec
STA
TRAVEL
721 Texas Ave. S. 979.696.5077
www.sttattravel
DUBAI, United Arab Emirates (AP) — Government-run
newspapers in Saudi Arabia have accused the country’s reli
gious police of preventing the rescue of girls trapped in a school
fire because they were not wearing the long dresses and head
coverings required in public.
Fourteen girls died in the catastrophe last Monday at the 31st
Girls Middle School in Mecca, some 470 miles southeast of Riyadh.
Fifty others were injured, while hundreds of others escaped.
The religious police, which have offices in every city, are
routinely criticized privately in Saudi society, but this was
believed to be the first time that newspapers in the kingdom
have come out with harsh words against them.
The newspapers accused members of the religious police —
the Committee for the Propagation of Virtue and the Prevention
of Vice — of blocking rescue attempts by male firefighters and
paramedics because some of the girls were not wearing the
mandatory Islamic dress, which covers the entire body and hair.
“They forced the girls to remain inside the school and didn’t
allow them to leave, saying that their hair wasn’t covered and
they weren't wearing the abaya (long robe),” the Al-Eqtisadiah
newspaper said, citing firefighters and police.
The government-run Saudi Gazette said 835 students and 55
teachers were in the building at the time of the fire, which broke
out a half-hour after classes started. The Saudi Press Agency said
I The Tex^
team will
spring drill
Bt 4 p.m.
I The Agg i
season wit
and wrapp
with a 28-S3
the Galie
Bowl in Ho
1 A&M retu
Including
Bhe lone lo
graduatin g
Beth McKin
50 games f
Renter. Seni
feethel Johr
■or the sprir
a ruptured
second garr
Rnd missed
■if the seasc
1 A&M will t
& White C
April 6 at 1 :
students started screaming, setting off a stampede fori
Initial reports said some gates were locked becaus
who had the key was away. But Al-Eqtisadiah quoted
fied civil police officers as saying that religiouspolia
the gate and refused to move even after rescuers/rift'
vince them that the situation was very serious.
According to the newspaper reports, most oi fe @
either suffocated, fell from the windows of the fas-W 5 ' 1
ing or were trampled to death. ^
The head of Mecca's police. Brig. Mohan ]
told The Associated Press on Sunday that he arrivedauP
to find a member of the religious police “trying toin'T
“He was fighting with a police officer, trying topflf
from entering the school,” al-Harthy said. “1 iMf
instructed him to leave and he did.” L
1 he director of the religious police, Sheik Jabet^w
denied his people prevented rescuers from entering T
I here are some who are trying to pin the death ofi :
on the committee,” he said.
The fire has led to a domestic debate and an intemat f
cry. with Amnesty International demanding a public
It these reports are true, this is a tragic illustraibl
gender discrimination can have lethal consequences, i
ization said in a written statement.
i Three-time
lion senior
turned in e
finish on tf
springboard
place finish c
to capture th
ing spot in t
Swimming
ChampionsFi
p In addition
more Katie W
ior Callie Petr
a spot in
Championshi
See B*
Contraceptive Injection corvtrol youirhink as.out jus-t M-xayear
medroxyprogesterone acetate injectable suspension
DEPO-PROVERA* Contraceptive Injection
(medroxyprogesterone acetate injectable suspension, USP)
This product is intended to prevent pregnancy. It does not protect against HIV
infection (AIDS) and other sexually transmitted diseases.
What is DEPO-PROVERA Contraceptive Injection?
DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an
intramuscular injection (a shot) in the buttock or upper arm once every 3 months (I 3 weeks). To
continue your contraceptive protection, you must return for your next injection promptly at the
end of 3 months (13 weeks) DEPO-PROVERA contains medroxyprogesterone acetate, a
chemical similar to (but not the same as) the natural hormone progesterone, which is produced
by your ovaries dunng the second half of your menstrual cycle. DEPO-PROVERa acts by
preventing your egg cells from ripening. If an egg is not released from the ovaries during your
menstrual cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA
also causes changes in the lining of your uterus that make it less likely for pregnancy to occur
How effective is DEPO-PROVERA Contraceptive Injection?
The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the
recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PROVERA
Contraceptive Injection?”) To make sure you are not pregnant when you first get
DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during
the first 5 days of a normal menstrual period, ONLY within the first 5 days after childbirth if not
breast-feeding; and, if exclusively breast-feeding, ONLY at the sixth week-after childbirth. It is a
long-term injectable contraceptive when administered at 3-month (13-week) intervals.
DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable
methods of birth control available. This means that the average annuaf pregnancy rate is less than
one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptVe
methods depends in part on how reliably each woman uses the method. The effectiveness of
DEPO-PROVEPA depends only on the patient returning every 3 months (I 3 weeks) for her next
injection. Your health-care provider will help you compare DEPO-PROVERA with other
contraceptive methods and give you the informatiorr you need in order to decide which
• if you have had cancer of the breast
• if you have had a stroke
• if you have or have had blood dots (phlebitis) in your legs
• if you have problems with your liver or liver disease
• if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other
ingredients).
What other things should I consider before using DEPO-PROVERA
Contraceptive Injection?
You will have a physical examination before your doctor prescribes DEPO-PROVERA It is
important to tell your health-care provider if you have any of the following:
• a family history of breast cancer
• an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or
bleeding from your nipples
• kidney disease
• irregular or scanty menstrual periods
• high blood pressure
• migraine headaches
*. asthma
• epilepsy (convulsions or seizures)
• diabetes or a family history of diabetes
• a history of depression
• if you are taking any prescription or over-the-counter medications
This product is intended to prevent pregnancy. It does not protect against
transmission of HIV (AIDS) and other sexually transmitted diseases such as
chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
<6 Other Riste hormone-based contraceptives may have an increased risk of blood clots or
Ateo if a contraceptive method fails, there Is a possibility that the fertilized egg will begm
inn outside of the uterus (ectopic pregnancy) While these events are rare, you should
to develop orovider if you have any of the problems listed in the next section
What symptoms maj signai probiems white using DEPO-PROVERA
oTy ofrhSbh<ah8^rov " e r immediately if any of these problems occur following an injection
? f sharp < chestpafn R cough.ng up of blood, or sudden shortness of breath (indicating a possible dot
. sudden" severe headache or vomiting, dizzinessorfaintiiw. problems with your eyesight or
s^eelh weakness, or numbness in an arm or leg ('"die at ing a possible stroke)
• severe pain or swelling In the calf (mdicating a possible dc? In the leg)
• unusually heavy vaginal bleeding abdominal area
• severe pain or tenderness n 1 ^Ttte
• persistent pain, pus, or bleeding at the injejcuonjite
What are the |
re the possible side effects of DEPO-PROVERA Contraceptive Injection?
vrvfrnav exocrience a weight gam while you are using DEPO-PROVERA About two thirds of
2°' J 5/hn used DEPO-PROVERA in clinical trials reported a weight gam of about 5 pounds
vea?ofYou may continue to gam weight after the finl year Women in one
f un ^ l DEPO PROVERA for 2 years gained an average total of 81 pounds ever
[Tf 3 ^r, or aocirovniately 4 pounds per year Women who continued for 4 years gained an
average toteTof I ^ pounds ^/er those 4 years, or ^
What if I want to become pregnant after using DEPO-PROVERA Contraceptive
Injection?
Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last
injection for its effect to wear off Eased on the results from a large study done in the United States,
for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that
e years, or appnoximatetv i s77* ' years gamed an
who continued for & years gained an average total of IA s e r2r,..kj Pounds per Y ear Women
approximately 2 75 pounds per year pounds over those 6 years or
In a clinical study of over 3,900 women who used DEPO-PROvco a <
women reported the following effects that may or mav not or U P 1
DEPO-PROVERA: Irregular menstrual bleeding, amenofrhe? ^.^? n . ne J a,e '
contraceptive method is the i
: choice , for you.
The following table shows the percent of women who got pregnant while using different kinds of
contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected
in women who use each method exactly as it should be used) and the typical rate of pregnancy
(which includes women who became pregnant because they lorgot to use their birth control or
because they did not follow the directions exactly).
Percent of Women Experiencing an Accidental Pregnancy
in the First Year of Continuous Use
bleeding amenon+iM "^ted^o thekuseof
about half of those who become pregnant will do so in about 10 months after their last injection, cramps, dizziness, weakness or fatigue, decreased sexual HocinJi e ‘ nervDusness . abdominal
about two thirds of those who become pregnant will do so in about 12 months; about 83% of discharge or irritation, breast swelling and tenderness bloatinn^'
those who become pregnant will do so in about 15 months; and about 93% of those who become backache, depression, insomnia, acne, pelvic pain, no hair
I irregular Menstrual Bleeding
months; and about 93% of those who become
of time you use
, it aft§r you stop using it
Contraceptive Injection?
discharge or irritation, breast swelling and tenderness bloatmo^/ t cra 7 > P s - n <»usea, vaginal
backache, depression, insomnia, acne, pelvic pain, no hair growth or^f ,n ^ ° f * he hands or feet,
flashes, and joint pain. Other problems were reported by very few Slve ha,r rash * hot
trials, but some of these could be serious. These include rrvrC,T;i °’ trvs ““
infections, alleryi.- f,intino c ?"vul S ,ons,
■h(H= ei I.? w , of the . women in the clinical
jaundice, urinary tract
~ ‘ vein
Student
Services
at A.P. Bee*
Health
will not be of
Wednesdaj
March 20,
rvic reactions, fainting, paralysis, osteoporosis lade of rl*t J aunc,,ce ' urinary
thrombosis, pulmonary embolus, breast cancer or cervical cAnrar ir* r Lf tum to <teep
The side effect reported most frequently by women who use DEPO-PROVERA for occur during your use of DEPO-PROVERA. discuss them ll he ¥ L or an / ot her problems
contraception is a change in their normal menstrual cycle During the first year of using Should any precautions be followed durinn '^•jH-caneprovider
DEPO-PROVERA. you might have one or more of the following changes irregular or Contraceptive Injection? y ® of DEPO-PROVERA
Method
Lowest
Expected
Typical
DEPO-PROVERA
0.3
0.3
Implants (Norplant)
0.2-
02*
Female sterilization
0.2
0.4
Male sterilization
0.1
0.15
Oral contraceptive (pill)
3
Combined
: 0.1
Progestogen only
0.5
IUD
3
Progestasert
2.0
Copper T 330A
0.8
Condom (without spermidde)
2
12
Diaphragn (with spermidde)
6
18
Cervical cap
6
18
Withdrawal
4
18
Periodic abstinence
1-9
20
Spermidde alone
3
21
Vaginal Sponge
used before childbirth
6
18
used after childbirth
9
28
No method
£5
, 85
unpredictable bleeding or spotting, an increase or decrease in menstrual bJeeddig, or no bleeding
at all. Unusually heavy or continuous bleeding, however; is not a usual effect of DEPO-PROVERA;
and if this hajipens.you should see your heafth-care provider right away. With continued use of perioas may
DEPO-PROVERA, bleed|ng^usuan/^decnsases. and many women stop having periods completely regularly ever
.1 many women stop r ^.,
In clinical studies of DEP'O-PROVERA, 55% of the women studied reported no menstrual
bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual
bleeding after 2 years of use The reason that your periods stop is because DEPO-PROVERA
causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the
. regular monthly growth of the lining of your uterus does not occur and. therefore, the bleeding
that comes with your normal menstruation does not take place. When you stop using
DEPO-PROVERA your menstrual period will usually, in time, return to its normal cycle.
2 Bone Mineral Changes
Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored in
your bones. This could increase your risk of developing bone fractures. The rate of bone mineral
loss is greatest in the early years of DEPO-PROVERA use, but after that, it begins to resemble the
normaT rate of age-nelated bone mineral loss.
SCancer
Studies of women who have used different forms of contraception found that women who used
DEPO-PROVERA for contraception had no increased overall risk of developing cancer of the
breast, ovary, uterus, cervix, or liver. However, women under 35 years of age whose first exposure
to DEPO-PROVERA was within the previous 4 to 5 years may have a slightly increased risk of
developing breast cancer similar to that seen with oral contraceptives. You should discuss this with
your healtn-care provider
4 .Unexpected Pregnancy
regularly every
that you may be pregnant, see your heaith-care provider
Test Interaction-
problib'ly^o^premarrt^'rr 0 ^^ 0 ^'^^®^
, , „ . .. r .vider pregnarrt ' Howe '^'-. if you think
2.Laboratory Test Interactions
If you are scheduled for any laboratory tests, tell your health
DEPO-PROVERA for contraception Certain blood ten- are that you
DEPO-PROVERA ests ane aff ected by hormones
'rug I
:adre
DEPO-PROVERA.
S.Drug Interactions
Q
- z — — •-> using
oy hormones such as
.^himide') is an anticancer drug that may significantly decrease the
^ re pe^s'ofEPO-PROVtRA if the two drugs are given during the same time.
e Nursing/Voters A
passed to the nursing infant in the breast milk, no harmful
Although DEP P f I-Tf lTth ese children DEPO-PROVERA does not prevent the breasts from
effects nave been i™™ d ^ nursing mothers. However to minimize the amount of
produdng milk ot it can be use |n the first after b|rth
5EPO-PROVERA that is passed to xne DEPO-PROVERA ''
6 weeks after childbirth before you, po _ pBOVERA Conlr ,
Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental
Source: Trussed et al. Obstet Gyneco/. l99Q76;558-567.
’•From Norplant® package insert.
Who should not use DEPO-PROVERA Contraceptive Injection?
Not all women should use DEPO-PROVERA You should not use DEPO-PROVERA if you have
any of the following conditions
• if you think you might be pregnant
• if you have any vaginal bleeding without a known reason
-miwuiu wait until
for contraceprtion
How often do I get my shot of DEPO-PROVERA Contraceptive Injection?
The recommended dose of DEPO-PROVERA is 150 mg every 3 months (13 weeks) given in a
single intramuscular injection in the buttock or upper arm To make sure that you are not pregnant
at f)ie time of the first in|ection, it is essential that the iniection be given ONLY during the first
5 days of a normal menstrual period. If used toiiowng the delivery of a child, the first infection of
DEPO-PROVERA MUST be given within 5 days after childbirth if you are not breast-feeding or
6 weeks after childbirth if you are exclusively breast-feeding. If you wait
/ 3 vJeeks! between miertinnc or lonoor than h "
,. _ regularly (every 3 months [13 weeks]) is very low. (I 3 weeks) between injections, or longer than 6 weeks after riel(2!l. wa ' t °r i 8 er than 3 months
While there have been reports of an increased risk of low birth weight and neonatal infant death should determine that you are not pregnant before givinp vm i your health-care provider
or other health problems in infants conceived dose to the time of injection, such pregnancies are 6 s ' u “ our Election of DEPO-PROVERA
uncommon. If you think you may have become pregnant while nsino DFPO-PROVFRA for Rx only ,
contraception, see your health-care provider as soon as possible.
SAIIergic Reactions
Some women using DEPO-PROVERA Contraceptive Injection have reported severe and
CB-7-S
potentially life-threatening allergic reactions known as anaphylaxis and anaphylactoid reactions. .
Symptoms include the sudden onset of hives or swelling and itching of the skin, breathing Pharmacia & Upj<
difficulties, and a drop in blood pressure. . Kalamazoo, Ml 4'
john Company
9001, USA
Pharmacia
& Upjohn
The sta
participate
an in-sen^
workshop" 1
Student Counst
Services.
Stof
on
Dial-A-Nutf
will resume
3:30 PM, March
do
EMS/Ambula' 1
Service
will be avails
(9-911)